Borrelidin is an angiogenesis inhibitor; Disruption of angiogenic capillary vessels in a rat aorta matrix culture model

Journal of Antibiotics

Volumn 50, Issue 8, 1997, Pages 671-676

  Wakabayashi, Toshiaki ^a   Kageyama, Rena ^a   Naruse, Nobuaki ^a   Tsukahara, Naoko ^a   Funahashi, Yasuhiro ^a   Kitoh, Kyosuke ^a   Watanabe, Yoshio ^b  

^a EISAI CO LTD   (Japan)

^b MERCIAN CORPORATION   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; BORRELIDIN; THREONINE TRANSFER RNA LIGASE;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA; APOPTOSIS; ARTICLE; CAPILLARY; CELL GROWTH; CELL STRAIN KB; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG POTENCY; DRUG STRUCTURE; ENDOTHELIUM CELL; GROWTH INHIBITION; HUMAN; HUMAN CELL; INTRAPERITONEAL DRUG ADMINISTRATION; LEUKEMIA P 388; MALE; MELANOMA B16; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; TUMOR VASCULARIZATION; UMBILICAL VEIN;

EID: 0030752706     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.7164/antibiotics.50.671     Document Type: Article

References (24)

1. FOLKMAN, J. & Y. SHING: Angiogenesis. J. Biol. Chem. 267: 10931-10934, 1992
2. FOLKMAN, J.: What is the evidence that tumors are angiogenesis dependent? J. Natl. Cancer Inst. 82: 4-6, 1990
3. INGBER, D.; T. FUJITA, S. KISHIMOTO, F. SUDO, T. KANAMARU, H. BREM & J. FOLKMAN: Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumour growth. Nature 348: 555-557, 1990
4. NAKAMURA, S.; S. SAKURADA, S. Z. SALAHUDDIN, Y. OSADA, N. G. TANAKA, N. SAKAMOTO, M. SEKIGUCHI & R. C. GALLO: Inhibition of development of Kaposi's sarcoma-related lesion by a bacterial cell wall complex. Science 255: 1432-1440, 1992
5. MAIONE, T. E.; G. S. GRAY, A. J. HUNT & R. J. SHARPE: Inhibition of tumor growth in mice by an analogue of platelet factor 4 that lacks affinity for heparin and retains potent angiostatic activity. Cancer Res. 51: 2077-2083, 1991
6. WANG, X.; X. FU, P. D. BROWN, M. J. CRIMMIN & R. M. HOFFMAN: Matrix metalloproteinase inhibitor BB-94 (batimastat) inhibits human colon tumor growth and spread in a patient-like orthotopic model in nude mice. Cancer Res. 54: 4726-4728, 1994
7. BAILLIE, C. T.; M. C. WINSLET & N. J. BRADLEY: Tumor vasculature - a potential therapeutic target. Br. J. Cancer 72: 257-267, 1995
8. MOSCATELLI, D. & D. B. RIFKIN: Membrane and matrix localization of proteinase: a common theme in tumor cell invasion and angiogenesis. Biochim. Biophys. Acta 948: 67-85, 1988
9. NICOSIA, R. F. & A. OTTINETTI: Growth of microvessels in serum-free matrix culture of rat aorta. Lab. Invest. 63: 115-122, 1990
10. NICOSIA, R. F.; S. V. NICOSIA & M. SMITH: Vascular endothelial growth factor, platelet-derived growth factor, and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro. Am. J. Pathol. 145: 1023-1029, 1994
11. BERGER, J.; L. M. JAMPOLSKY & M. W. GOLDBERG: Borrelidin, a new antibiotic with anti-borrelia activity and penicillin enhancement properties. Arch. Biochem. 22: 476-478, 1949
12. BUCK, M.; A. C. FARR, & R. J. SCHNITZER: The anti-borrelia effect of borrelidin. Trans. N. Y. Acad. Sci., Ser. 11: 207, 1949
13. SINGH, S. K.; S. GURUSIDDAIAH & J. WHALEN: Treponemycin, a nitrole antibiotic active against Treponema hyodysenteriae. Antimicrob. Agents Chemother. 27: 239-245, 1985
14. LUMB, M.; P. E. MACEY, J. SPYVEE, J. M. WHITMARSH & R. D. WRIGHT: Isolation of vivomycin and borrelidin, two antibiotics with anti-viral activity, from a species of Streptomyces (C2989). Nature 206: 263-265, 1965
15. DICKINSON, L.; A. J. GRIFFITHS, C. G. MASON & R. F. N. MILLS: Anti-viral activity of two antibiotics isolated from a species of Streptomyces. Nature 206: 265-268, 1965
16. PAETZ, W. & G. NASS: Biochemical and immunological characterization of threonyl-tRNA synthetase of two borrelidin- resistant mutants of Escherichia coli K12. Eur. J. Biochem. 35: 331-337, 1973
17. GANTT, J. S.; C. A. BENNETT & S. M. ARFIN: Increased levels of threonyl-tRNA synthetase in a borrelidin-resistant Chinese hamster ovary cell line. Proc. Natl. Acad. Sci. USA 78: 5367-5370, 1981
18. GAVRIELI, Y.; Y. SHERMAN & A. BEN-SASSON: Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119: 493-501, 1992
19. VILLASCHI, S. & R. F. NICOSIA: Angiogenic role of endogenous basis fibroblast growth factor released by rat aorta after injury. Am. J. Pathol. 143: 181-190, 1993
20. TANAKA, N. G.; N. SAKAMOTO, K. INOUE, H. KORENAGA, S. KADOYA, H. OGAWA & Y. OSADA: Antitumor effects of an antiangiogenic polysaccharide from an Arthrobacter species with or without a steroid. Cancer Res. 49: 6727-6730, 1989
21. LATERRA, J. & G. W. GOLDSTEIN: Astroglial-induced in vitro angiogenesis: requirements for RNA and protein synthesis. J. Neurochem. 57: 1231-1239, 1991
22. OLEINICK, N. L.: Initiation and elongation of protein synthesis in growing cells: differential inhibition by cycloheximide and emetine. Arch. Biochem. Biophys. 182: 171-180, 1977
23. OGAWARA, H.; Y. HASUMI, K. HIGASHI, Y. ISHII, T. SAITO, S. WATANABE, K. SUZUKI, M. KOBORI, K. TANAKA & T. AKIYAMA: Acetoxycycloheximide and cycloheximide convert transformed morphology of ras-transformed cells to normal morphology. J. Antibiotics 42: 1530-1533, 1989
24. 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79: 1157-1164, 1994